Citigroup Inc Artivion, Inc. Transaction History

Citigroup Inc

$169 Billion
Q3 2024

A detailed history of Citigroup Inc transactions in Artivion, Inc. stock. As of the latest transaction made, Citigroup Inc holds 48,801 shares of AORT stock, worth $1.38 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

48,801

Previous 27,651 76.49%

Holding current value

$1.38 Million

Previous $709,000 83.22%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$24.33 - $28.46 $514,579 - $601,929	21,150 Added 76.49%	48,801 $1.3 Million
Q2 2024 Aug 12, 2024	BUY	$19.62 - $25.65 $53,130 - $69,460	2,708 Added 10.86%	27,651 $709,000
Q1 2024 May 10, 2024	BUY	$16.7 - $21.63 $31,579 - $40,902	1,891 Added 8.2%	24,943 $527,000
Q4 2023 Feb 09, 2024	BUY	$12.33 - $18.83 $103,029 - $157,343	8,356 Added 56.86%	23,052 $412,000
Q3 2023 Nov 09, 2023	SELL	$14.82 - $17.52 $209,495 - $247,662	-14,136 Reduced 49.03%	14,696 $222,000
Q2 2023 Aug 10, 2023	BUY	$12.78 - $17.23 $134,892 - $181,862	10,555 Added 57.75%	28,832 $495,000
Q1 2023 May 11, 2023	SELL	$11.74 - $14.12 $69,183 - $83,209	-5,893 Reduced 24.38%	18,277 $239,000
Q4 2022 Feb 09, 2023	BUY	$10.01 - $13.9 $47,167 - $65,496	4,712 Added 24.22%	24,170 $292,000
Q3 2022 Nov 10, 2022	BUY	$13.31 - $23.25 $21,122 - $36,897	1,587 Added 8.88%	19,458 $269,000
Q2 2022 Aug 10, 2022	SELL	$15.73 - $22.91 $250,531 - $364,887	-15,927 Reduced 47.12%	17,871 $337,000
Q1 2022 May 12, 2022	BUY	$16.95 - $21.74 $64,477 - $82,698	3,804 Added 12.68%	33,798 $723,000
Q4 2021 Feb 10, 2022	BUY	$17.19 - $22.84 $136,179 - $180,938	7,922 Added 35.89%	29,994 $610,000
Q3 2021 Nov 10, 2021	BUY	$22.29 - $28.7 $491,984 - $633,466	22,072 New	22,072 $492,000

Others Institutions Holding AORT

# of Institutions

175

Shares Held

36M

Call Options Held

33K

Put Options Held

900

View Full List

About ARTIVION, INC.

Ticker AORT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 40,316,100
Market Cap $1.14B
Description
Artivion Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide. The company offers BioGlue, a polymer consisting of bovine blood protein and an agent for cross-linking proteins for cardiac, vascular, neurologic, and pulmonary procedures; cardiac preservation services; PhotoFix, a bovine pericardial...

More about AORT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.

Account